Mandyam D. Ravi

Mysore, KA, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Adult Immunisation in a South Indian Tertiary Care Hospital: Who Benefits, What's Safe, and What Holds Us Back?

Adult Immunisation in a South Indian Tertiary Care Hospital: Who Benefits, What's Safe, and What Holds Us Back?

Journal: Journal of primary care & community health
Published: November 25, 2025

Understanding adverse events following immunisation: evidence of vaccine safety and coincidental events from 3 years of surveillance.

Understanding adverse events following immunisation: evidence of vaccine safety and coincidental events from 3 years of surveillance.

Journal: BMJ paediatrics open
Published: September 19, 2025

Chronic Immune Thrombocytopenia Purpura Following COVID-19 Vaccination (ChAdOx1 -nCov-19): A Case Report With OneYear Follow-Up.

Chronic Immune Thrombocytopenia Purpura Following COVID-19 Vaccination (ChAdOx1 -nCov-19): A Case Report With OneYear Follow-Up.

Journal: Hospital pharmacy
Published: September 25, 2024

Mapping changes in the utilization of childhood immunization over 5 years in a south Indian tertiary care hospital.

Mapping changes in the utilization of childhood immunization over 5 years in a south Indian tertiary care hospital.

Journal: Therapeutic advances in vaccines and immunotherapy
Published: May 22, 2024

Immunogenicity and safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14™) administered to 6-8 weeks old healthy Indian Infants: A single blind, randomized, active-controlled, Phase-III study.

Immunogenicity and safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14™) administered to 6-8 weeks old healthy Indian Infants: A single blind, randomized, active-controlled, Phase-III study.

Journal: Vaccine
Published: December 22, 2023

A randomized, active-controlled, multi-centric, phase-II clinical study to assess safety and immunogenicity of a fully liquid DTwP-HepB-IPV-Hib hexavalent vaccine (HEXASIIL®) in Indian toddlers.

A randomized, active-controlled, multi-centric, phase-II clinical study to assess safety and immunogenicity of a fully liquid DTwP-HepB-IPV-Hib hexavalent vaccine (HEXASIIL®) in Indian toddlers.

Journal: Vaccine
Published: November 08, 2023

COVID-19 vaccine triggered autoimmune hepatitis: case report.

COVID-19 vaccine triggered autoimmune hepatitis: case report.

Journal: European journal of hospital pharmacy : science and practice
Published: August 17, 2023

Immunogenicity and safety of HavisureTM vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study.

Immunogenicity and safety of HavisureTM vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study.

Journal: Vaccine
Published: April 25, 2023

A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL®) in infants.

A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL®) in infants.

Journal: NPJ vaccines
Published: March 24, 2023

Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India.

Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India.

Journal: Expert review of vaccines
Published: March 08, 2023

COVID-19 vaccine triggered autoimmune hepatitis: case report.

COVID-19 vaccine triggered autoimmune hepatitis: case report.

Journal: European journal of hospital pharmacy : science and practice
Published: August 01, 2022

A Rare Pediatric Case of Cefixime Induced Toxic Epidermal Necrolysis.

A Rare Pediatric Case of Cefixime Induced Toxic Epidermal Necrolysis.

Journal: Hospital pharmacy
Published: May 23, 2022
Showing 1-12 of 31

Last Updated: 09/26/2026